VaxGen gets $878 million US contract
506288
The federal government awarded an $878 million anthrax vaccine contract to a Brisbane biotech company Thursday, ordering a stockpile of 75 million doses to guard against terrorist attacks.
330955
US consumer healthcare company Perrigo is to buy Israeli drug-maker Agis for $818m (Â£441.5m) in cash and stock. The deal will create a firm with annual sales of $1.
364081
Sep 21, 2004 (CIDRAP News) - In a bid to limit the threat of an influenza pandemic, the Department of Health and Human Services (HHS) is awarding a contract to Aventis Pasteur Inc.
507533
ID Biomedical Corp. IDB.TO IDBE.O  signed a 10-year U.S. distribution deal for its Fluviral drug  that could reap sales of $2.3 billion and help U.S. authorities  fill a flu vaccine shortage, the company said on Monday.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
281494
The US government announced Thursday that it has awarded an $877.5 million contract to a private company to manufacture and deliver 75 million doses of a new vaccine for inhalation anthrax.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.
267992
Dying of lung cancer, Carolyn Hobbs tried a new biotechnology drug that produced an unanticipated side effect: acute sticker shock. She was waiting for her second treatment in a hospital near Denver less than two years ago, when someone from the business office marched in to warn that her share would cost more than $18,000, since the drug wasn't insured for her type of cancer.
683062
By Tom Spoth, The Sun, Lowell, Mass.  Feb. 11--In February 2004, a company in Burlington received a $2.5 million contract from the U.S. Army.
203734
GlaxoSmithKline Plc  has signed a  drug discovery deal with U.S. biotech firm ChemoCentryx  potentially worth up to $1.5 billion in milestone payments and  research funding to the privately owned group.
254726
Thermo Electron Corp., the biggest maker of analytical instruments for medical labs, has bought laboratory software maker InnaPhase Corp. for about $65 million. InnaPhase, of Philadelphia, has about 100 employees and expects revenue of $26 million this year, Waltham-based Thermo Electron said. Thermo had about 10,800 employees and $2.1 billion in sales in 2003. It sold an optics unit to ...
423289
Research and Markets (http://www.researchandmarkets.com/reports/c49959)  has announced the addition of V-Tek Technology Co., Ltd.: 2006 Contract  Manufacturing Profile to their offering.  V-Tek Technology Co., Ltd.
260762
Shares of ID Biomedical jumped after the Canadian drug maker reported Monday that it signed long-term agreements with the three largest flu vaccine wholesalers in the United States following the current flu season&#39;s vaccine shortage.
138104
Human Genome Sciences could see more than $180 million from a new deal with drug maker GlaxoSmithKline. Glaxo has acquired exclusive rights to an experimental drug called Albugon, which Human Genome Sciences
674084
AUCKLAND, Oct 19  - A company that supports the US science programme in Antarctica has been awarded a 546 million dollar extension to its contract, the US National Science Foundation (NSF) said in a statement Tuesday.
595051
U.S. health officials agreed to buy  1.2 million doses of influenza vaccine made by GlaxoSmithKline  on Tuesday and said another 2.8 million doses from the company  will be available later during the flu season.
736904
Computer Sciences Corp. won a $1.35 billion contract to manage phone and computer networks for Ascension Health, the biggest US nonprofit health care system.